Alpha Tau Medical (DRTS) News Today $10.04 -0.92 (-8.39%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$10.20 +0.17 (+1.64%) As of 05/22/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Alpha Tau Medical Dropping Today?Toggle Visibility of Why Is Alpha Tau Medical Dropping Today?Alpha Tau Medical Ltd. (NASDAQ: DRTS) is moving lower after a cluster of analyst notes from HC Wainwright, which reiterated a Buy rating and $15 price target but cut several earnings forecasts. The revised estimates suggest continued losses, with HC Wainwright now modeling FY2026 EPS at -$0.67 versus its prior -$0.53 view, while trimming near-term quarterly EPS forecasts as well. Positive Sentiment: HC Wainwright kept a Buy rating on Alpha Tau Medical and maintained a $15.00 price objective, implying meaningful upside from current levels. Neutral Sentiment: The firm’s latest estimates still point to ongoing losses, with multiple quarters projected at -$0.14 EPS and FY2027 EPS at -$0.55, but these figures were broadly in line with the existing subscale profitability outlook. Negative Sentiment: HC Wainwright lowered earnings estimates for Q2 2026, Q3 2026, Q4 2026, and FY2026, signaling a weaker near-term profit outlook for Alpha Tau Medical. Overall, the stock is down today because investors appear to be focusing more on the downward earnings revisions than on the bullish rating and price target.Posted 1+ days agoAI Generated. May Contain Errors. DRTS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period HC Wainwright Has Pessimistic Outlook of DRTS Q2 EarningsMay 22 at 5:53 AM | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Receives "Buy" Rating from HC WainwrightMay 21 at 3:15 AM | americanbankingnews.comAlpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year High on Analyst UpgradeMay 20 at 1:34 AM | americanbankingnews.comDRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This WeekMay 19, 2026 | msn.comAlpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive PayMay 18, 2026 | tipranks.comAlpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate UpdateMay 18, 2026 | globenewswire.comAlpha Tau to Participate in May Investor ConferencesMay 18, 2026 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Average Rating of "Hold" from AnalystsMay 18, 2026 | americanbankingnews.comAlpha Tau Medical (DRTS) price target increased by 13.16% to 10.96May 14, 2026 | msn.comAlpha Tau Medical (NASDAQ:DRTS) Price Target Raised to $14.00 at LADENBURG THALM/SH SHMay 13, 2026 | americanbankingnews.comAlpha Tau Medical (NASDAQ:DRTS) Price Target Raised to $15.00 at HC WainwrightMay 13, 2026 | americanbankingnews.comAlpha Tau Medical (NASDAQ:DRTS) Sets New 52-Week High - Time to Buy?May 11, 2026 | marketbeat.comAlpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma StudyMay 11, 2026 | marketbeat.comDRTS stock surges pre-market even as retail traders debate 'too small' brain cancer trial dataMay 11, 2026 | msn.comAlpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ETMay 11, 2026 | globenewswire.comAlpha Tau Medical (DRTS) Expected to Announce Earnings on MondayMay 11, 2026 | marketbeat.comAlpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell ...May 8, 2026 | markets.businessinsider.comAlpha Tau Completes Enrollment in Pivotal U.S. Skin Cancer Trial for Alpha DaRTMay 8, 2026 | tipranks.comAlpha Tau Medical Completes Enrollment in Pivotal ReSTART Trial for Alpha DaRT in Recurrent Cutaneous Squamous Cell CarcinomaMay 8, 2026 | quiverquant.comQAlpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent GlioblastomaMay 8, 2026 | globenewswire.comAlpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell CarcinomaMay 8, 2026 | globenewswire.comAlpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas InstituteMay 7, 2026 | markets.businessinsider.comAlpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona's Pancreas InstituteMay 7, 2026 | globenewswire.comAlpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer ...May 5, 2026 | markets.businessinsider.comAlpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with PembrolizumabMay 5, 2026 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Still a Buy?May 4, 2026 | marketbeat.comAlpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026May 4, 2026 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year High - Time to Buy?May 2, 2026 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Sees Strong Trading Volume - Here's What HappenedMay 1, 2026 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Trading Up 13.6% - Here's What HappenedApril 30, 2026 | marketbeat.comAlpha Tau Medical Ltd. Announces Acceptance of Abstract at ASCO Annual Meeting Highlighting Alpha DaRT's Efficacy in Pancreatic CancerApril 27, 2026 | quiverquant.comQAlpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer StudiesApril 27, 2026 | globenewswire.comDRTS stock pops pre-market: Retail hype soars on cancer trial expansionApril 24, 2026 | msn.comAlpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel)April 23, 2026 | globenewswire.comAlpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical TrialApril 23, 2026 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from BrokeragesApril 23, 2026 | marketbeat.comAlpha Tau Medical Ltd. Announces Acceptance of Abstract on Alpha DaRT® for Pancreatic Cancer at Digestive Disease Week 2026March 31, 2026 | quiverquant.comQAlpha Tau Announces First-Ever Oral Presentation of Alpha DaRT® Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026March 31, 2026 | globenewswire.comDRTS stock is back on retail radar ahead of high-stakes cancer trial updatesMarch 30, 2026 | msn.comAlpha Tau Medical: 2026 Is The Breakthrough YearMarch 24, 2026 | seekingalpha.comAlpha Tau to Present at Sidoti March Virtual Small Cap ConferenceMarch 16, 2026 | globenewswire.comAlpha Tau Announces Full Year 2025 Financial Results and Provides Corporate UpdateMarch 9, 2026 | globenewswire.comHekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRTFebruary 24, 2026 | businesswire.comAlpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer TherapyFebruary 24, 2026 | tipranks.comAlpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck CancerFebruary 24, 2026 | globenewswire.comAlpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones AheadJanuary 29, 2026 | globenewswire.comAlpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026January 23, 2026 | seekingalpha.comAlpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026January 6, 2026 | msn.comAlpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic ...January 6, 2026 | finance.yahoo.comAlpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® StudyJanuary 6, 2026 | globenewswire.com Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos DRTS Media Mentions By Week DRTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRTS News Sentiment▼0.000.44▲Average Medical News Sentiment DRTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRTS Articles This Week▼203▲DRTS Articles Average Week Get the Latest News and Ratings for DRTS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alpha Tau Medical and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies WRBY News MMED News SLNO News TMDX News LMAT News AXGN News NVCR News ESTA News PLSE News PRCT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRTS) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
